August 18 – Parsippany, NJ - Extremity Medical, LLC announced that it has agreed with Neosteo, a French orthopedic device manufacturer, to the exclusive US distribution rights for the DynafitSystem®.
The DynafitSystem® is a 510(k) cleared device approved for use in bone fracture and reconstruction in forefoot surgery. Matt Lyons, Chairman, and CEO of Extremity Medical commented, “The DynafitSystem® provides Extremity Medical with a comprehensive forefoot osteosynthesis solution. The design features and high quality production of this comprehensive screw offering make this a highly competitive system.”
Benoît Gayraud, President, and CEO of Neosteo stated, “Extremity Medical is a strong partner for Neosteo because of its goal to become a world leader in the surgical treatment of small bone and joints, a segment of the orthopedic market that continues to grow rapidly.”
Extremity Medical, LLC is an orthopedic device company specializing in the development of next generation systems addressing unmet needs for the extremity surgeon. The company currently has 11products released globally, which include specialized fixation and advanced arthroplasty systems for the lower and upper extremities. The company’s products are covered by an extensive portfolio of existing and pending patents.
Published at OrthoWorld